Benutzer: Gast  Login
Dokumenttyp:
journal article 
Autor(en):
Harrabi, S B; Bougatf, N; Mohr, A; Haberer, T; Herfarth, K; Combs, S E; Debus, J; Adeberg, S 
Titel:
Dosimetric advantages of proton therapy over conventional radiotherapy with photons in young patients and adults with low-grade glioma. 
Abstract:
Low-grade glioma (LGG) is a very common brain tumor in pediatric patients typically associated with a very good prognosis. This prognosis makes it imperative that the risk of long-term treatment-related side effects be kept at an absolute minimum. Proton therapy (PRT) provides a radiation technique that has the potential to further reduce the genesis of radiogenic impairment.We retrospectively assessed 74 patients with LGG who underwent PRT. Conventional three-dimensional photon and PRT plans were generated after contouring structures of neurogenesis, crucial neuronal structures, and areas susceptible to secondary malignancies. Target volume coverage was evaluated using the homogeneity index (HI) and inhomogeneity coefficient (IC). Results were compared using the Wilcoxon-signed rank test, with p< 0.05 being statistically significant.Target volume coverage was comparable for the photon and proton plans. Overall, we could show an essential reduction in maximal, mean, and integral doses in critical neurologic structures, areas of neurogenesis, and structures of neurocognitive function. The study indicated specifically how contralaterally located structures could be spared with PRT.PRT is a highly conformal radiation technique offering superior dosimetric advantages over conventional radiotherapy by allowing significant dose reduction for organs at risk (OAR) that are essential for neurologic function, neurocognition, and quality of life, thus demonstrating the potential of this technique for minimizing long-term sequelae. 
Zeitschriftentitel:
Strahlenther Onkol 
Jahr:
2016 
Band / Volume:
192 
Heft / Issue:
11 
Seitenangaben Beitrag:
759-769 
Sprache:
eng 
Print-ISSN:
0179-7158 
TUM Einrichtung:
Klinik und Poliklinik für RadioOnkologie und Strahlentherapie